MR Imaging of Benign Uterine Disease

Brown MA, Michèle A Brown
Magnetic resonance imaging clinics of North America · 2006 · vol. 14(4) , pp. 439–453 · doi:10.1016/j.mric.2007.01.006 · PMID:17433976 · W1988775597
review OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This paper reviews the use of MRI for diagnosing and characterizing benign uterine conditions such as fibroids, adenomyosis, and congenital anomalies.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

MR provides excellent depiction of the female pelvic anatomy and has become the imaging modality of choice for the accurate diagnosis of numerous benign gynecologic conditions. Detection and characterization of leiomyomata and adenomyosis is performed routinely at many centers, and MR plays an important role in stratifying patients into appropriate treatment options. MR imaging is also uniquely well suited to the evaluation of gynecologic conditions that occur during pregnancy and in the postpartum period. This article describes MR protocols and the typical findings of various benign conditions of the uterine corpus and cervix, including congenital anomalies, leiomyomas, adenomyosis, and complications related to pregnancy.

My notes (saved in your browser only)

MeSH descriptors

Magnetic Resonance Imaging Uterine Diseases Contrast Media Diagnosis, Differential Female Humans Magnetic Resonance Imaging Pregnancy Pregnancy Complications Pregnancy Complications Uterine Diseases Uterine Diseases Uterus Uterus Uterus

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (57)

Cited by (2)

Source provenance

europepmc
last seen: 2026-07-29T06:27:48.050232+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:15:00.519696+00:00
License: CC0 · commercial use OK